Balcinrenone/dapagliflozin

DRUG3 trials

Sponsors

AstraZeneca

Conditions

Healthy VolunteerKidney FailureRenal Insufficiency, Chronic

Phase 1

A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants

CompletedNCT06651021

AstraZenecaHealthy Volunteer

Start: 2024-10-21End: 2024-10-28Updated: 2025-01-15

Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin

RecruitingNCT07754331

AstraZenecaKidney Failure

Start: 2026-08-06End: 2026-12-03Target: 10Updated: 2026-09-04

Phase 3

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

Not yet recruitingNCT07624305

AstraZenecaRenal Insufficiency, Chronic

Start: 2026-09-01End: 2030-07-01Target: 2800Updated: 2026-06-03